1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends
Spinal Intervention: Markets for Surgical, Replacement and Neurostimulation Technologies

Spinal Intervention: Markets for Surgical, Replacement and Neurostimulation Technologies

  • January 2017
  • 181 pages
  • ID: 4579511
  • Format: PDF
  • By BCC Research

Summary

Table of Contents


Use this report to:
- Measure a broad understanding of the market for spinal interventional products, as well as the markets for adjacent but complementary products and technologies.
- Analyze the market in terms of key product and technology areas, major manufacturers and factors influencing market growth.
- Provide a more comprehensive analysis of the overall market and growth opportunities for companies operating in the spinal interventional market.
- Discuss major stakeholders, product portfolios and recent developments, and to draw a competitive landscape for the market leaders in the spinal interventional market.


Highlights
- The global market for spinal and neurostimulation intervention products is expected to reach $15.8 billion by 2021 from $12.6 billion in 2016, rising at a compound annual growth rate (CAGR) of 4.5% from 2016 through 2021.
- The spinal surgery segment of spinal intervention market is the largest sector. The market is expected to grow from $9.0 billion in 2016 to $10.8 billion in 2021 at a CAGR of 3.5% for the period 2016-2021.
- The neurostimulation devices segment of spinal intervention market is expected to grow from $3.6 billion in 2016 to $5.0 billion in 2021 at a CAGR of 6.9% for the period 2016-2021.


STUDY GOALS AND OBJECTIVES
This report, Spinal Intervention: Markets for Surgical, Replacement and Neurostimulation Technologies, provides an in-depth analysis of the markets for spinal and neurostimulation products. It aims to provide readers with a broad understanding of the market for spinal interventional products, as well as the markets for adjacent but complementary products and technologies.


REASONS FOR DOING THE STUDY
In the U.S. alone, back pain has an estimated direct cost of over $50 billion annually for diagnosis, treatment and rehabilitation. Currently, it is estimated that there are approximately 65 million people in the U.S. alone with chronic back pain. The treatment of back pain depends much on the root cause. Generally, pharmaceuticals and/or physical therapy are the first-line treatments. However, should these not work, spinal surgery may be an option for some patients. Currently, over 1 million spinal surgeries are performed each year. Given the aging population, these rates are expected to continue to increase in coming years, leading to a good market opportunity for companies working in this space.

As an alternative to spinal surgery, neurostimulation has become a new option for the treatment of lower back pain in recent years. In addition to treating pain, neurostimulation can be used to treat unwanted neurological or psychological symptoms, as well as to enhance muscular activity. As such, neurostimulation can be used, or is being investigated for use, to treat a wide range of conditions, including chronic migraine, cluster headache, Parkinson’s disease, essential tremor, dystonia, epilepsy, overactive bladder, fecal incontinence, gastroparesis, obesity, gastroesophageal reflux disease, sleep apnea, treatment-resistant hypertension, obsessive-compulsive disorder, depression, heart failure, Alzheimer’s disease, tinnitus and upper-limb deficit after stroke. This is a dynamic and growing market that is attracting increasing interest from manufacturers, surgeons and patients alike.


SCOPE OF REPORT
The report provides an analysis of the markets for spinal and neurostimulation products, including trends and sales to 2021. It analyzes the market in terms of key product and technology areas, major manufacturers and factors influencing market growth.

Manufacturers of neurostimulation and spinal technologies are discussed and analyzed based on product types, market share and key corporate activities, including a mergers and acquisitions, strategic alliances, and research and development. In addition to neurostimulation products used for the treatment of spinal conditions, the report looks at the wider neurostimulation industry in order to provide a more comprehensive analysis of the overall market and growth opportunities for companies operating in this field.

The report also includes an in-depth analysis of new products and technologies in development, as well as the development of new products that can address a growing number of therapeutic indications. Excluded from the scope of the report are spinal soft goods, bracing products and externally worn neurostimulation devices.


INTENDED AUDIENCE The report is intended for anyone interested in gaining a better understanding of the spinal implant and neurostimulation markets. This may include company executives working in these areas, those planning or contemplating investing in the market, companies actively or considering pursuing market entry, component or materials manufacturers whose products may be relevant to the industry, suppliers and distributors working in this field. In addition, the report would be of interest to venture capitalists, clinicians, trade associations, research organizations and government bodies with an interest in spinal and neurostimulation products and technologies.


INFORMATION SOURCES
The information contained in the report comes from a wide range of primary and secondary sources. Financial and market data are derived from U.S. Securities and Exchange Commission filings, company annual reports and other financial reports, company investor presentations, trade associations, industry associations and company executives. Product and technology sources include company press releases and websites, information from professional organization and industry conferences, medical research papers and medical journal articles, U.S. Patent Office filings and U.S. Food and Drug Administration databases and resources, as well as similar sources available for countries other than the U.S.

Other major sources of information include government bodies such as the U.S. Center of Disease Control and Prevention, the U.S. Department of Health and Human Services and the World Health Organization, as well as similar bodies in other countries. In addition, the report has been complied with the help of direct communication with company executives, including CEOs, product managers, marketing managers, investor relations and research and development staff.


ANALYST'S CREDENTIALS Joanne Maddox is an experienced healthcare industry analyst specializing on the medical device and diagnostics markets. She has 16 years of experience working specifically in this niche area. Her work has included competitor and market insight, due diligence assistance, market forecasting and trend analysis of the medical devices industry, with a key focus on orthopedic and spinal technologies, implantable electronic devices, diagnostics, medical imaging and wound care.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Huntington Disease - Pipeline Review, H2 2019

Huntington Disease - Pipeline Review, H2 2019

  • $ 2000
  • December 2019

Huntington Disease - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease - Pipeline Review, H2 2019, provides an overview of the Huntington ...

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • November 2019

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019SummaryMedical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019" provides an ...

Diabetes Assays - Medical Devices Pipeline Assessment, 2019

Diabetes Assays - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • November 2019

Diabetes Assays - Medical Devices Pipeline Assessment, 2019SummaryMedical Devices sector report, “Diabetes Assays - Medical Devices Pipeline Assessment, 2019" provides an overview of Diabetes Assays ...

Wounds - Pipeline Review, H2 2019 $ 2000 December 2019

Malaria - Pipeline Review, H2 2019 $ 2000 December 2019


ref:plp2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on